A potential cure for a rare type of blood cancer is currently being used to treat 150 patients at various healthcare centers ...

A nurse practitioner gives her advice for managing adverse events during treatment with talquetamab for multiple myeloma.

In the evolving landscape of haematologic cancers, the concept of minimal residual disease, also known as measurable residual ...

Multiple myeloma is a disease that most people haven’t heard of until it impacts their lives directly. This blood cancer can sound daunting but understanding it is the first step towards ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms ...

Bispecific antibodies enhance immune response by targeting myeloma and immune cells ... leading to several dermatologic and sensory side effects, such as rashes, dry skin and brittle nails, with some ...

He sought a second opinion at Fred Hutch Cancer Center, where a full body scan revealed that Crow had multiple myeloma. “I didn’t know what that was,” said Crow. “All I knew was that I had an ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Talquetamab (Talvey), a bispecific T cell engager, offers a promising treatment option for relapsed/refractory multiple myeloma ... nail changes, and skin rashes. Dysgeusia often occurs early, even ...

Are an adult with relapsed or refractory multiple myeloma Have tried at least four previous lines of treatments for multiple myeloma, including: Immune system modulators (help boost the immune ...

Keep reading to learn about rashes, bruises, spots ... and arms. Later-stage multiple myeloma can damage the kidneys. As the kidneys start to fail, this can lead to symptoms including itching ...